Article citationsMore >>

Storms, William W., and Judi E. Miller. “Daily Use of Guaifenesin (Mucinex) in a Patient with Chronic Bronchitis and Pathologic Mucus Hypersecretion: A Case Report.” Respir Med Case Rep 23 (February 2018): 156-57.

has been cited by the following article:

Article

Assessment and Treatment of Mucus Hypersecretion in COPD: A Case Study

1Arjun Medical Center, Gainesville, VA, USA


American Journal of Medical Case Reports. 2021, Vol. 9 No. 12, 730-733
DOI: 10.12691/ajmcr-9-12-18
Copyright © 2021 Science and Education Publishing

Cite this paper:
Kami Whitney PA-C. Assessment and Treatment of Mucus Hypersecretion in COPD: A Case Study. American Journal of Medical Case Reports. 2021; 9(12):730-733. doi: 10.12691/ajmcr-9-12-18.

Correspondence to: Kami  Whitney PA-C, Arjun Medical Center, Gainesville, VA, USA. Email: kamirenee@gmail.com

Abstract

Mucus hypersecretion is a debilitating feature of COPD that is often overlooked and under treated by clinicians despite its contribution to declining lung function and quality of life. This case study explores the use of the COPD Assessment Test in the evaluation of mucus hypersecretion and improvements in quality of life related to this symptom after the addition of guaifenesin as part of a comprehensive COPD care plan.

Keywords